Induction of Human Anti-Human Antibody Responses (Ab2) after Application of a Humanized Lewis Y Carbohydrate Specific Antibody (Ab1): Connection of Prolonged Disease Stabilization with Ab3 Induction?

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.net/journal/jct
E-mail: [email protected]

Citations

"Induction of Human Anti-Human Antibody Responses (Ab2) after Application of a Humanized Lewis Y Carbohydrate Specific Antibody (Ab1): Connection of Prolonged Disease Stabilization with Ab3 Induction?"
written by Andreas Nechansky, Stefan Stranner, Oliver Scheiber, Nicole Halanek, Ralf Kircheis,
published by Journal of Cancer Therapy, Vol.3 No.4, 2012

has been cited by the following article(s):

[1]	Safety and Therapeutic Efficacy of the Lewis Y Carbohydrate Specific Humanized Antibody MB311 in Patients with Malignant Effusion
	Journal of Cancer Therapy, 2013

Top

[1]	Developments in the Production of Recombinant Monoclonal Antibodies Biotechnology Journal, 2025 DOI:10.1002/biot.70127

[2]	Safety and Therapeutic Efficacy of the Lewis Y Carbohydrate Specific Humanized Antibody MB311 in Patients with Malignant Effusion Journal of Cancer Therapy, 2014 DOI:10.4236/jct.2014.51004